We are live on ! Find out more
GHRS icon

GH Research

32 hedge funds and large institutions have $299M invested in GH Research in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.36% less ownership

Funds ownership: 60.74%59.39% (-1.4%)

6% less funds holding

Funds holding: 3432 (-2)

14% less capital invested

Capital invested by funds: $348M → $299M (-$48.9M)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.51%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
2
Increased
10
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change

GHRS Hedge Fund Activity: Q4 2022 in Review

32 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in GH Research (GHRS) for Q4 2022, worth a combined $299M — down 14% from $348M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of GHRS and 2 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 10 added.

The largest buyer was Verition Fund Management, adding an estimated $3.13M. The largest seller was Fidelity Investments, cutting an estimated $6.02M.

  • 32 institutional investors held GH Research (GHRS) as of Q4 2022, down from 34 in Q3 2022.
  • Funds reported $299M of GH Research stock for Q4 2022, down 14% quarter-over-quarter.
  • 2 funds opened new GH Research positions in Q4 2022 and 3 closed out, a net change of -1 holder.
  • The largest GH Research buyer in Q4 2022 was Verition Fund Management, an estimated $3.13M added.
  • The largest GH Research seller in Q4 2022 was Fidelity Investments, an estimated $6.02M sold.

Based on aggregated 13F filings for Q4 2022.